These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28488248)

  • 1. Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF
    Bystrom J; Clanchy FI; Taher TE; Al-Bogami MM; Muhammad HA; Alzabin S; Mangat P; Jawad AS; Williams RO; Mageed RA
    Clin Rev Allergy Immunol; 2017 Oct; 53(2):265-276. PubMed ID: 28488248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.
    Wang XD; Wang YL; Gao WF
    Int J Clin Exp Pathol; 2015; 8(7):7929-36. PubMed ID: 26339358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
    Guo X; Higgs BW; Bay-Jensen AC; Wu Y; Karsdal MA; Kuziora M; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Rheumatology (Oxford); 2018 Jan; 57(1):175-184. PubMed ID: 29069507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis.
    Guo X; Wang S; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Int J Rheum Dis; 2019 Apr; 22(4):646-653. PubMed ID: 30358109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
    Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
    Front Immunol; 2018; 9():2228. PubMed ID: 30319663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum GM-CSF level is a predictor of treatment response to tocilizumab in rheumatoid arthritis patients: a prospective observational cohort study.
    Su J; Hu W; Ding Y; Zhang P; Li T; Liu S; Xing L
    Arthritis Res Ther; 2024 Jul; 26(1):130. PubMed ID: 38997725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial.
    Taylor PC; Saurigny D; Vencovsky J; Takeuchi T; Nakamura T; Matsievskaia G; Hunt B; Wagner T; Souberbielle B;
    Arthritis Res Ther; 2019 Apr; 21(1):101. PubMed ID: 30999929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β and TNFα promote monocyte viability through the induction of GM-CSF expression by rheumatoid arthritis synovial fibroblasts.
    Darrieutort-Laffite C; Boutet MA; Chatelais M; Brion R; Blanchard F; Heymann D; Le Goff B
    Mediators Inflamm; 2014; 2014():241840. PubMed ID: 25484525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.
    Gullick NJ; Abozaid HS; Jayaraj DM; Evans HG; Scott DL; Choy EH; Taams LS
    Clin Exp Immunol; 2013 Nov; 174(2):292-301. PubMed ID: 23815507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway.
    Alzabin S; Abraham SM; Taher TE; Palfreeman A; Hull D; McNamee K; Jawad A; Pathan E; Kinderlerer A; Taylor PC; Williams R; Mageed R
    Ann Rheum Dis; 2012 Oct; 71(10):1741-8. PubMed ID: 22550316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restored and Enhanced Memory T Cell Immunity in Rheumatoid Arthritis After TNFα Blocker Treatment.
    Khanniche A; Zhou L; Jiang B; Song J; Jin Y; Yin J; Wang S; Ji P; Shen H; Wang Y; Xu H
    Front Immunol; 2019; 10():887. PubMed ID: 31105703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of therapy with chimeric monoclonal tumour necrosis factor-alpha antibodies on intracellular cytokine profiles of T lymphocytes and monocytes in rheumatoid arthritis patients.
    Schuerwegh AJ; Van Offel JF; Stevens WJ; Bridts CH; De Clerck LS
    Rheumatology (Oxford); 2003 Apr; 42(4):541-8. PubMed ID: 12649401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes.
    Olszewski WL; Pazdur J; Kubasiewicz E; Zaleska M; Cooke CJ; Miller NE
    Arthritis Rheum; 2001 Mar; 44(3):541-9. PubMed ID: 11263768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha.
    Parsonage G; Filer A; Bik M; Hardie D; Lax S; Howlett K; Church LD; Raza K; Wong SH; Trebilcock E; Scheel-Toellner D; Salmon M; Lord JM; Buckley CD
    Arthritis Res Ther; 2008; 10(2):R47. PubMed ID: 18433499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy.
    Wright HL; Bucknall RC; Moots RJ; Edwards SW
    Rheumatology (Oxford); 2012 Mar; 51(3):451-9. PubMed ID: 22179732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis synovial fluid shows enrichment of T-cells producing GMCSF which are polyfunctional for TNFα and IFNγ.
    Khullar A; Dhir V; Saikia B; Yadav AK; Leishangthem B; Prasad CB; Jayaprakash S; Jain S; Naidu GSRSNK; Sharma SK; Sharma A; Jain S
    Clin Exp Rheumatol; 2024 Jul; 42(7):1435-1441. PubMed ID: 38372731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.
    Hu D; Tjon EC; Andersson KM; Molica GM; Pham MC; Healy B; Murugaiyan G; Pochet N; Kuchroo VK; Bokarewa MI; Weiner HL
    Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30639-30648. PubMed ID: 33203678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.